Investigating the Antiangiogenic, Anti-drug Resistance and Apoptotic Effects of Soy Isoflavone Extract Alone or in Combination with Docetaxel on Murine 4T1 Breast Tumor Model
- 18 September 2017
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 69 (7) , 1036-1042
Abstract
Background: One major concern in the treatment of cancer patients during chemotherapy is drug resistance. Here we investigated the effects of soy isoflavone extracts alone or in combination with Docetaxel on the drug resistance, angiogenesis, apoptosis, and tumor volume in mouse 4T1 breast tumor model. Methods: Sixty female BALB/c mice were randomly divided into 4 groups: control, dietary soy isoflavone extract [Iso, 100 mg/kg diet (0.01%)], Docetaxel (10 mg/kg) injection, and the combination of dietary soy isoflavone extract and intravenous Docetaxel injection (Docetaxel + Iso). One week after the third injection, the breast tumors of eight mice from each group were excised to analyze NF-κBp65′ vascular endothelial growth factor receptor-2 (VEGFR2) and Pgp gene and protein expressions and the other seven mice were monitored for survival rate analysis until they died. Results: NF-κBp65 gene and protein expressions were significantly lower in the Docetaxel + Iso group in comparison with that of the Docetaxel group. VEGFR2 protein expression in the Docetaxel + Iso and Iso groups was significantly lower than that of the Docetaxel group. Conclusion: These findings may indicate that the combined use of isoflavone extracts together with chemotherapeutic agents has more efficient anti-carcinogenic effects than their individual use.Keywords
This publication has 20 references indexed in Scilit:
- Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancerMolecular Cancer, 2013
- Individual and combined soy isoflavones exert differential effects on metastatic cancer progressionClinical & Experimental Metastasis, 2010
- Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET studyNuclear Medicine and Biology, 2008
- Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signalingExperimental Hematology, 2007
- Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer CellsCancer Research, 2005
- Genistein alters growth factor signaling in transgenic prostate model (TRAMP)Molecular and Cellular Endocrinology, 2004
- Anticancer drug resistance in primary human brain tumorsBrain Research Reviews, 2001
- NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma CellsJournal of Biological Chemistry, 1997
- Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoproteinBiochemical Pharmacology, 1997
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996